Changes in Mycobacterium tuberculosis-Specific Immunity With Influenza co-infection at Time of TB Diagnosis
Prior Influenza A viral (IAV) infection has been shown to increase susceptibility to tuberculosis (TB) and TB has also been shown to be a primary cause of death during pandemics, including the Spanish Influenza outbreak of 1918-1919. The majority of data has been obtained from mouse models, thus the...
Saved in:
Published in | Frontiers in immunology Vol. 9; p. 3093 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
Frontiers Media S.A
04.01.2019
|
Subjects | |
Online Access | Get full text |
ISSN | 1664-3224 1664-3224 |
DOI | 10.3389/fimmu.2018.03093 |
Cover
Abstract | Prior Influenza A viral (IAV) infection has been shown to increase susceptibility to tuberculosis (TB) and TB has also been shown to be a primary cause of death during pandemics, including the Spanish Influenza outbreak of 1918-1919. The majority of data has been obtained from mouse models, thus the aim of this study was to determine the impact of Flu co-infection on host immunity and disease severity in TB patients at diagnosis.
Sputum from 282 patients with active TB were analyzed for presence of FluA/FluB RNA at presentation using multiplex PCR. Sputum RNA was also analyzed for
(Mtb) load using
S RNA amplification. Supernatants from digested sputum and Mtb antigen-stimulated whole blood were analyzed using multiplex cytokine arrays and PBMC were analyzed for cytokine production from CD4+ T, CD8+ T and Mucosal Associated Invariant T cells (MAITs).
12 (4.3%) of TB patients were found to have FluA or FluB viral RNA present in their sputum at the time of TB diagnosis. The TB/Flu co-infected patients had a significantly higher bacterial load compared to those with TB mono-infection (
= 0.0026). They had lower levels of IL17A in
sputum (
= 0.0275) and higher MCP-1 (CCL2) levels in the blood following PPD stimulation (
= 0.0267). TB/Flu co-infected subjects had significantly higher IFN-γ+IL-17+CD4+ and IFN-γ+IL-17-CD8+ cells compared to TB mono-infected subjects.
These data show that Flu co-infection at time of TB diagnosis is associated with a higher bacterial load and differential cellular and soluble profiles. These findings show for the first time the impact of TB/Flu co-infection in a human cohort and support the potential benefit of Flu vaccination in TB-endemic settings. |
---|---|
AbstractList | Background: Prior Influenza A viral (IAV) infection has been shown to increase susceptibility to tuberculosis (TB) and TB has also been shown to be a primary cause of death during pandemics, including the Spanish Influenza outbreak of 1918-1919. The majority of data has been obtained from mouse models, thus the aim of this study was to determine the impact of Flu co-infection on host immunity and disease severity in TB patients at diagnosis. Methods: Sputum from 282 patients with active TB were analyzed for presence of FluA/FluB RNA at presentation using multiplex PCR. Sputum RNA was also analyzed for Mycobacterium tuberculosis (Mtb) load using 16S RNA amplification. Supernatants from digested sputum and Mtb antigen-stimulated whole blood were analyzed using multiplex cytokine arrays and PBMC were analyzed for cytokine production from CD4+ T, CD8+ T and Mucosal Associated Invariant T cells (MAITs). Results: 12 (4.3%) of TB patients were found to have FluA or FluB viral RNA present in their sputum at the time of TB diagnosis. The TB/Flu co-infected patients had a significantly higher bacterial load compared to those with TB mono-infection (p = 0.0026). They had lower levels of IL17A in ex vivo sputum (p = 0.0275) and higher MCP-1 (CCL2) levels in the blood following PPD stimulation (p = 0.0267). TB/Flu co-infected subjects had significantly higher IFN-γ+IL-17+CD4+ and IFN-γ+IL-17-CD8+ cells compared to TB mono-infected subjects. Conclusions: These data show that Flu co-infection at time of TB diagnosis is associated with a higher bacterial load and differential cellular and soluble profiles. These findings show for the first time the impact of TB/Flu co-infection in a human cohort and support the potential benefit of Flu vaccination in TB-endemic settings.Background: Prior Influenza A viral (IAV) infection has been shown to increase susceptibility to tuberculosis (TB) and TB has also been shown to be a primary cause of death during pandemics, including the Spanish Influenza outbreak of 1918-1919. The majority of data has been obtained from mouse models, thus the aim of this study was to determine the impact of Flu co-infection on host immunity and disease severity in TB patients at diagnosis. Methods: Sputum from 282 patients with active TB were analyzed for presence of FluA/FluB RNA at presentation using multiplex PCR. Sputum RNA was also analyzed for Mycobacterium tuberculosis (Mtb) load using 16S RNA amplification. Supernatants from digested sputum and Mtb antigen-stimulated whole blood were analyzed using multiplex cytokine arrays and PBMC were analyzed for cytokine production from CD4+ T, CD8+ T and Mucosal Associated Invariant T cells (MAITs). Results: 12 (4.3%) of TB patients were found to have FluA or FluB viral RNA present in their sputum at the time of TB diagnosis. The TB/Flu co-infected patients had a significantly higher bacterial load compared to those with TB mono-infection (p = 0.0026). They had lower levels of IL17A in ex vivo sputum (p = 0.0275) and higher MCP-1 (CCL2) levels in the blood following PPD stimulation (p = 0.0267). TB/Flu co-infected subjects had significantly higher IFN-γ+IL-17+CD4+ and IFN-γ+IL-17-CD8+ cells compared to TB mono-infected subjects. Conclusions: These data show that Flu co-infection at time of TB diagnosis is associated with a higher bacterial load and differential cellular and soluble profiles. These findings show for the first time the impact of TB/Flu co-infection in a human cohort and support the potential benefit of Flu vaccination in TB-endemic settings. Prior Influenza A viral (IAV) infection has been shown to increase susceptibility to tuberculosis (TB) and TB has also been shown to be a primary cause of death during pandemics, including the Spanish Influenza outbreak of 1918-1919. The majority of data has been obtained from mouse models, thus the aim of this study was to determine the impact of Flu co-infection on host immunity and disease severity in TB patients at diagnosis. Sputum from 282 patients with active TB were analyzed for presence of FluA/FluB RNA at presentation using multiplex PCR. Sputum RNA was also analyzed for (Mtb) load using S RNA amplification. Supernatants from digested sputum and Mtb antigen-stimulated whole blood were analyzed using multiplex cytokine arrays and PBMC were analyzed for cytokine production from CD4+ T, CD8+ T and Mucosal Associated Invariant T cells (MAITs). 12 (4.3%) of TB patients were found to have FluA or FluB viral RNA present in their sputum at the time of TB diagnosis. The TB/Flu co-infected patients had a significantly higher bacterial load compared to those with TB mono-infection ( = 0.0026). They had lower levels of IL17A in sputum ( = 0.0275) and higher MCP-1 (CCL2) levels in the blood following PPD stimulation ( = 0.0267). TB/Flu co-infected subjects had significantly higher IFN-γ+IL-17+CD4+ and IFN-γ+IL-17-CD8+ cells compared to TB mono-infected subjects. These data show that Flu co-infection at time of TB diagnosis is associated with a higher bacterial load and differential cellular and soluble profiles. These findings show for the first time the impact of TB/Flu co-infection in a human cohort and support the potential benefit of Flu vaccination in TB-endemic settings. Background: Prior Influenza A viral (IAV) infection has been shown to increase susceptibility to tuberculosis (TB) and TB has also been shown to be a primary cause of death during pandemics, including the Spanish Influenza outbreak of 1918–1919. The majority of data has been obtained from mouse models, thus the aim of this study was to determine the impact of Flu co-infection on host immunity and disease severity in TB patients at diagnosis.Methods: Sputum from 282 patients with active TB were analyzed for presence of FluA/FluB RNA at presentation using multiplex PCR. Sputum RNA was also analyzed for Mycobacterium tuberculosis (Mtb) load using 16S RNA amplification. Supernatants from digested sputum and Mtb antigen-stimulated whole blood were analyzed using multiplex cytokine arrays and PBMC were analyzed for cytokine production from CD4+ T, CD8+ T and Mucosal Associated Invariant T cells (MAITs).Results: 12 (4.3%) of TB patients were found to have FluA or FluB viral RNA present in their sputum at the time of TB diagnosis. The TB/Flu co-infected patients had a significantly higher bacterial load compared to those with TB mono-infection (p = 0.0026). They had lower levels of IL17A in ex vivo sputum (p = 0.0275) and higher MCP-1 (CCL2) levels in the blood following PPD stimulation (p = 0.0267). TB/Flu co-infected subjects had significantly higher IFN-γ+IL-17+CD4+ and IFN-γ+IL-17-CD8+ cells compared to TB mono-infected subjects.Conclusions: These data show that Flu co-infection at time of TB diagnosis is associated with a higher bacterial load and differential cellular and soluble profiles. These findings show for the first time the impact of TB/Flu co-infection in a human cohort and support the potential benefit of Flu vaccination in TB-endemic settings. Background: Prior Influenza A viral (IAV) infection has been shown to increase susceptibility to tuberculosis (TB) and TB has also been shown to be a primary cause of death during pandemics, including the Spanish Influenza outbreak of 1918–1919. The majority of data has been obtained from mouse models, thus the aim of this study was to determine the impact of Flu co-infection on host immunity and disease severity in TB patients at diagnosis. Methods: Sputum from 282 patients with active TB were analyzed for presence of FluA/FluB RNA at presentation using multiplex PCR. Sputum RNA was also analyzed for Mycobacterium tuberculosis (Mtb) load using 16 S RNA amplification. Supernatants from digested sputum and Mtb antigen-stimulated whole blood were analyzed using multiplex cytokine arrays and PBMC were analyzed for cytokine production from CD4+ T, CD8+ T and Mucosal Associated Invariant T cells (MAITs). Results: 12 (4.3%) of TB patients were found to have FluA or FluB viral RNA present in their sputum at the time of TB diagnosis. The TB/Flu co-infected patients had a significantly higher bacterial load compared to those with TB mono-infection ( p = 0.0026). They had lower levels of IL17A in ex vivo sputum ( p = 0.0275) and higher MCP-1 (CCL2) levels in the blood following PPD stimulation ( p = 0.0267). TB/Flu co-infected subjects had significantly higher IFN-γ+IL-17+CD4+ and IFN-γ+IL-17-CD8+ cells compared to TB mono-infected subjects. Conclusions: These data show that Flu co-infection at time of TB diagnosis is associated with a higher bacterial load and differential cellular and soluble profiles. These findings show for the first time the impact of TB/Flu co-infection in a human cohort and support the potential benefit of Flu vaccination in TB-endemic settings. |
Author | Kampmann, Beate Heslop, Rhiannon Sutherland, Jayne S. Bojang, Adama L. Jarju, Sheikh Mendy, Joseph |
AuthorAffiliation | 1 Vaccines & Immunity Theme, MRC Unit The Gambia at the London School of Hygiene & Tropical Medicine , Banjul , Gambia 2 Faculty of Biosciences, The University of Manchester , Manchester , United Kingdom |
AuthorAffiliation_xml | – name: 1 Vaccines & Immunity Theme, MRC Unit The Gambia at the London School of Hygiene & Tropical Medicine , Banjul , Gambia – name: 2 Faculty of Biosciences, The University of Manchester , Manchester , United Kingdom |
Author_xml | – sequence: 1 givenname: Joseph surname: Mendy fullname: Mendy, Joseph – sequence: 2 givenname: Sheikh surname: Jarju fullname: Jarju, Sheikh – sequence: 3 givenname: Rhiannon surname: Heslop fullname: Heslop, Rhiannon – sequence: 4 givenname: Adama L. surname: Bojang fullname: Bojang, Adama L. – sequence: 5 givenname: Beate surname: Kampmann fullname: Kampmann, Beate – sequence: 6 givenname: Jayne S. surname: Sutherland fullname: Sutherland, Jayne S. |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30662443$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kk1vEzEQhi1UREvonRPykcsGf2f3ggThK1IRB4I4Wl7vOHHZtcvaixR-Pd6kVC0SPtiW_c4zY8_7FJ2FGACh55QsOa-bV84Pw7RkhNZLwknDH6ELqpSoOGPi7N7-HF2mdE3KEA3nXD5B55woxYTgF-jHem_CDhL2AX8-2Ngam2H004Dz1MJopz4mn6qvN2C98xZvSs7g8wF_93mPN8H1E4TfBttY-eDAZh8DNhlv_QA4Orx9i995swsz5Rl67Eyf4PJ2XaBvH95v15-qqy8fN-s3V5UViuWKyVKbMoqoGlhtO8rEPBGqmHMrWYtGECFZY0ExIy1fSeCNocBbbuSKA1-gzYnbRXOtb0Y_mPGgo_H6eBDHnTZj9rYH7Rx1BdYRK41QYFrZSSpryrq6nX-ssF6fWDdTO0BnIeTR9A-gD2-C3-td_KUVZ7Uo5SzQy1vAGH9OkLIefLLQ9yZAnJJmdDW_h8i6SF_cz3WX5G-3ioCcBHaMKY3g7iSU6NkT-ugJPXtCHz1RQtQ_IdZnM3epVOv7_wf-Ad76vJ8 |
CitedBy_id | crossref_primary_10_1007_s11274_023_03636_x crossref_primary_10_1038_s41590_019_0444_8 crossref_primary_10_2174_2666796703666220705144250 crossref_primary_10_3389_fimmu_2023_1240419 crossref_primary_10_1038_s41467_022_30914_3 crossref_primary_10_1038_s41541_020_0189_2 crossref_primary_10_1007_s15010_021_01576_y crossref_primary_10_2478_jtim_2020_0010 crossref_primary_10_1016_j_mehy_2019_109505 crossref_primary_10_1371_journal_ppat_1010093 crossref_primary_10_7717_peerj_7443 crossref_primary_10_1126_scisignal_abe1621 crossref_primary_10_1186_s12879_020_05194_1 crossref_primary_10_1016_j_it_2024_07_008 crossref_primary_10_1128_CMR_00094_21 crossref_primary_10_1002_1873_3468_13488 crossref_primary_10_1016_j_virs_2025_03_005 crossref_primary_10_1055_s_0042_1760409 crossref_primary_10_1097_EC9_0000000000000039 crossref_primary_10_1002_ppul_27232 crossref_primary_10_3390_jcm14072154 |
Cites_doi | 10.4049/jimmunol.1401088 10.1016/j.coi.2013.03.011 10.1186/s12879-015-0746-x 10.1189/jlb.1211619 10.2807/ese.14.42.19369-en 10.1093/infdis/jit424 10.1371/journal.pone.0129173 10.1038/nri2960 10.1038/nature09247 10.1126/science.1233665 10.1371/journal.pone.0168272 10.1371/journal.pone.0008459 10.3201/eid2403.152071 10.4049/jimmunol.1202824 10.1016/j.vaccine.2011.02.053 10.1038/nri3166 |
ContentType | Journal Article |
Copyright | Copyright © 2019 Mendy, Jarju, Heslop, Bojang, Kampmann and Sutherland. 2019 Mendy, Jarju, Heslop, Bojang, Kampmann and Sutherland |
Copyright_xml | – notice: Copyright © 2019 Mendy, Jarju, Heslop, Bojang, Kampmann and Sutherland. 2019 Mendy, Jarju, Heslop, Bojang, Kampmann and Sutherland |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM DOA |
DOI | 10.3389/fimmu.2018.03093 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals (ODIN) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 1664-3224 |
ExternalDocumentID | oai_doaj_org_article_ff1f045d0c5a46eab5d515812d8b0000 PMC6328457 30662443 10_3389_fimmu_2018_03093 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | Gambia |
GeographicLocations_xml | – name: Gambia |
GrantInformation_xml | – fundername: Medical Research Council grantid: MC_UP_A900_1122 – fundername: Medical Research Council grantid: MC_EX_MR/K011944/1 – fundername: Medical Research Council grantid: MC_UU_00026/2 – fundername: Medical Research Council grantid: MC_EX_MR/P024270/1 – fundername: Medical Research Council grantid: MC_U190071468 |
GroupedDBID | 53G 5VS 9T4 AAFWJ AAKDD AAYXX ACGFO ACGFS ACXDI ADBBV ADRAZ AENEX AFPKN ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV CITATION DIK EBS EMOBN GROUPED_DOAJ GX1 HYE KQ8 M48 M~E OK1 PGMZT RNS RPM CGR CUY CVF ECM EIF IPNFZ NPM RIG 7X8 5PM |
ID | FETCH-LOGICAL-c462t-256246a6068e28cd124cd120162ff75849404529ce62a5c375e39a1e3b3a573e3 |
IEDL.DBID | M48 |
ISSN | 1664-3224 |
IngestDate | Wed Aug 27 01:30:41 EDT 2025 Thu Aug 21 18:30:25 EDT 2025 Fri Sep 05 13:14:19 EDT 2025 Sat May 31 02:14:06 EDT 2025 Tue Jul 01 01:35:40 EDT 2025 Thu Apr 24 23:01:14 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | influenza cytokines flow cytometry bacterial load tuberculosis |
Language | English |
License | This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c462t-256246a6068e28cd124cd120162ff75849404529ce62a5c375e39a1e3b3a573e3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 This article was submitted to Microbial Immunology, a section of the journal Frontiers in Immunology Edited by: Christoph Hölscher, Forschungszentrum Borstel (LG), Germany Reviewed by: Bianca Schneider, Forschungszentrum Borstel (LG), Germany; Warwick Britton, University of Sydney, Australia |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.3389/fimmu.2018.03093 |
PMID | 30662443 |
PQID | 2179404058 |
PQPubID | 23479 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_ff1f045d0c5a46eab5d515812d8b0000 pubmedcentral_primary_oai_pubmedcentral_nih_gov_6328457 proquest_miscellaneous_2179404058 pubmed_primary_30662443 crossref_primary_10_3389_fimmu_2018_03093 crossref_citationtrail_10_3389_fimmu_2018_03093 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2019-01-04 |
PublicationDateYYYYMMDD | 2019-01-04 |
PublicationDate_xml | – month: 01 year: 2019 text: 2019-01-04 day: 04 |
PublicationDecade | 2010 |
PublicationPlace | Switzerland |
PublicationPlace_xml | – name: Switzerland |
PublicationTitle | Frontiers in immunology |
PublicationTitleAlternate | Front Immunol |
PublicationYear | 2019 |
Publisher | Frontiers Media S.A |
Publisher_xml | – name: Frontiers Media S.A |
References | Walzl (B6) 2011; 11 Redford (B9) 2014; 209 Flórido (B12) 2013; 191 Yen (B13) 2018; 24 Pasman (B1) 2012; 85 McNab (B10) 2014; 193 Braciale (B8) 2012; 12 Heslop (B15) 2016; 11 Kumar (B14) 2013; 25 Walaza (B4) 2015; 10 Hasan (B16) 2009; 4 Archer (B3) 2009; 14 Walaza (B5) 2015; 15 Jurado (B17) 2012; 91 Teles (B11) 2013; 339 Berry (B7) 2010; 466 Noymer (B2) 2011; 29 |
References_xml | – volume: 193 start-page: 3600 year: 2014 ident: B10 article-title: Type I IFN induces IL-10 production in an IL-27-independent manner and blocks responsiveness to IFN-γ for production of IL-12 and bacterial killing in Mycobacterium tuberculosis-infected macrophages publication-title: J Immunol. doi: 10.4049/jimmunol.1401088 – volume: 25 start-page: 373 year: 2013 ident: B14 article-title: Th17 cell-based vaccines in mucosal immunity publication-title: Curr Opin Immunol. doi: 10.1016/j.coi.2013.03.011 – volume: 15 start-page: 26 year: 2015 ident: B5 article-title: Influenza virus infection is associated with increased risk of death amongst patients hospitalized with confirmed pulmonary tuberculosis in South Africa, 2010–2011 publication-title: BMC Infect Dis. doi: 10.1186/s12879-015-0746-x – volume: 91 start-page: 991 year: 2012 ident: B17 article-title: IL-17 and IFN-γ expression in lymphocytes from patients with active tuberculosis correlates with the severity of the disease publication-title: J Leukoc Biol. doi: 10.1189/jlb.1211619 – volume: 14 start-page: 19369 year: 2009 ident: B3 article-title: Interim report on pandemic H1N1 influenza virus infections in South Africa, April to October 2009: epidemiology and factors associated with fatal cases publication-title: Euro Surveill. doi: 10.2807/ese.14.42.19369-en – volume: 85 start-page: 127 year: 2012 ident: B1 article-title: The complication of coinfection publication-title: Yale J Biol Med. – volume: 209 start-page: 270 year: 2014 ident: B9 article-title: Influenza A virus impairs control of Mycobacterium tuberculosis coinfection through a Type I interferon receptor-dependent pathway publication-title: J Infect Dis. doi: 10.1093/infdis/jit424 – volume: 10 start-page: e0129173 year: 2015 ident: B4 article-title: Excess mortality associated with influenza among tuberculosis deaths in South Africa, 1999–2009 publication-title: PLoS ONE doi: 10.1371/journal.pone.0129173 – volume: 11 start-page: 343 year: 2011 ident: B6 article-title: Immunological biomarkers of tuberculosis publication-title: Nat Rev Immunol. doi: 10.1038/nri2960 – volume: 466 start-page: 973 year: 2010 ident: B7 article-title: An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis publication-title: Nature doi: 10.1038/nature09247 – volume: 339 start-page: 1448 year: 2013 ident: B11 article-title: Type I interferon suppresses Type II interferon-triggered human anti-mycobacterial responses publication-title: Science doi: 10.1126/science.1233665 – volume: 11 start-page: e0168272 year: 2016 ident: B15 article-title: Changes in host cytokine patterns of TB patients with different bacterial loads detected using 16S rRNA analysis publication-title: Plos ONE doi: 10.1371/journal.pone.0168272 – volume: 4 start-page: e8459 year: 2009 ident: B16 article-title: CCL2 responses to Mycobacterium tuberculosis are associated with disease severity in tuberculosis publication-title: PLoS ONE doi: 10.1371/journal.pone.0008459 – volume: 24 start-page: 498 year: 2018 ident: B13 article-title: Influenza vaccination and incident tuberculosis among elderly persons, Taiwan publication-title: Emerg Infect Dis. doi: 10.3201/eid2403.152071 – volume: 191 start-page: 302 year: 2013 ident: B12 article-title: Influenza A virus infection impairs mycobacteria-specific T cell responses and mycobacterial clearance in the lung during pulmonary coinfection publication-title: J Immunol. doi: 10.4049/jimmunol.1202824 – volume: 29 start-page: B38 year: 2011 ident: B2 article-title: The 1918 influenza pandemic hastened the decline of tuberculosis in the United States: an age, period, cohort analysis publication-title: Vaccine doi: 10.1016/j.vaccine.2011.02.053 – volume: 12 start-page: 295 year: 2012 ident: B8 article-title: Regulating the adaptive immune response to respiratory virus infection publication-title: Nat Rev Immunol. doi: 10.1038/nri3166 |
SSID | ssj0000493335 |
Score | 2.3415596 |
Snippet | Prior Influenza A viral (IAV) infection has been shown to increase susceptibility to tuberculosis (TB) and TB has also been shown to be a primary cause of... Background: Prior Influenza A viral (IAV) infection has been shown to increase susceptibility to tuberculosis (TB) and TB has also been shown to be a primary... Background: Prior Influenza A viral (IAV) infection has been shown to increase susceptibility to tuberculosis (TB) and TB has also been shown to be a primary... |
SourceID | doaj pubmedcentral proquest pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 3093 |
SubjectTerms | Adult Bacterial Load Cohort Studies Coinfection - blood Coinfection - diagnosis Coinfection - immunology Coinfection - microbiology cytokines DNA, Bacterial - isolation & purification Female flow cytometry Gambia Humans Immunology influenza Influenza A virus - genetics Influenza A virus - immunology Influenza A virus - isolation & purification Influenza B virus - genetics Influenza B virus - immunology Influenza B virus - isolation & purification Influenza, Human - blood Influenza, Human - diagnosis Influenza, Human - immunology Influenza, Human - virology Male Mycobacterium tuberculosis - genetics Mycobacterium tuberculosis - immunology Mycobacterium tuberculosis - isolation & purification RNA, Ribosomal, 16S - genetics RNA, Viral - isolation & purification Sputum - microbiology tuberculosis Tuberculosis, Pulmonary - blood Tuberculosis, Pulmonary - diagnosis Tuberculosis, Pulmonary - immunology Tuberculosis, Pulmonary - microbiology Young Adult |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals (ODIN) dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LS8QwEA4iCF7Et-uLCF48xN1tkj6OPlFBT4reQpImWHVbse1h_fVOkt1lV0QvXnpoUzrMTDLfNJNvEDpMM2n7acxIIhknjOYxUYr3iKQ9E6ksAojuqy3u4qsHdvPEn6ZafbmasEAPHBTXtbZvAXbkPc0li41UPIcQDGEpTz3AcasvhLGpZOol4F5KKQ_7kpCFZV1bDAatK-VKj_3u30wc8nT9P2HM76WSU7HnchktjUAjPgnCrqA5U66ihdBGcriGXsMRgRoXJb4dapihnoG5HeCmVeZDt29VXdTEt5q3hcbX_kxIM8SPRfOMr0Obkk-JdUXGtVkllg12x0NwZfH9KT4PFXlFvY4eLi_uz67IqIkC0SyOGgKQJmKxhDwlNVGqc4jn7gJIL7IWkgWWMceqnmkTR5JrmnBDM9k3VFHJE2roBpovq9JsIWyNhfltrALNsiQBezDILy0gzLyfKK47qDtWqdAjhnHX6OJNQKbhjCC8EYQzgvBG6KCjyRvvgV3jl7GnzkqTcY4X298AbxEjbxF_eUsHHYxtLGAeuc0RWZqqrUXkViZY0XjaQZvB5pNPUUeTzxiIkMx4w4wss0_K4tlzdccU4j9Ptv9D-B20COrI_A8gtovmm4_W7AEkatS-9_4v6GcJrQ priority: 102 providerName: Directory of Open Access Journals |
Title | Changes in Mycobacterium tuberculosis-Specific Immunity With Influenza co-infection at Time of TB Diagnosis |
URI | https://www.ncbi.nlm.nih.gov/pubmed/30662443 https://www.proquest.com/docview/2179404058 https://pubmed.ncbi.nlm.nih.gov/PMC6328457 https://doaj.org/article/ff1f045d0c5a46eab5d515812d8b0000 |
Volume | 9 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1664-3224 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000493335 issn: 1664-3224 databaseCode: KQ8 dateStart: 20100101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1664-3224 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000493335 issn: 1664-3224 databaseCode: DOA dateStart: 20100101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 1664-3224 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000493335 issn: 1664-3224 databaseCode: DIK dateStart: 20100101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVFQY databaseName: GFMER Free Medical Journals customDbUrl: eissn: 1664-3224 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000493335 issn: 1664-3224 databaseCode: GX1 dateStart: 20100101 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 1664-3224 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000493335 issn: 1664-3224 databaseCode: M~E dateStart: 20100101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVAQN databaseName: PubMed Central (Free e-resource, activated by CARLI) customDbUrl: eissn: 1664-3224 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000493335 issn: 1664-3224 databaseCode: RPM dateStart: 20100101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine – providerCode: PRVFZP databaseName: Scholars Portal Journals: Open Access customDbUrl: eissn: 1664-3224 dateEnd: 20250131 omitProxy: true ssIdentifier: ssj0000493335 issn: 1664-3224 databaseCode: M48 dateStart: 20101001 isFulltext: true titleUrlDefault: http://journals.scholarsportal.info providerName: Scholars Portal |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwELZKERIXxJttoTISQuLgduNXkgNCFCgtUjl1xd4sx7HbwG7SbhKJ5dcztrMrFq0QFx8SJ37M2P7GHs-H0Kss1y7JJCep5oJwVkpSFGJMNBtbWuQUIHrwtvgqTyf8y1RMd9DqdsnQge1W087zSU0Ws8OfN8t3MODfeosT1tsjV83nvffSyg7Dwd7r6xviaaX88evAsXEL3Yalinq1Px_w__cIjxkLJJyJhPqCcvN4lLn1vxtLV4jwvw2W_u1d-cdydXIf3RtwJn4fFeMB2rH1Q3QnMk8uH6Ef8VZBi6sany8NDOoQtLmf464v7ML0s6atWhLY6V1l8Fm4RtIt8bequ8Jnkdnkl8amISt3rhrrDvsbJbhx-OIYf4xOfFX7GE1OPl18OCUD7wIxXNKOAAqiXGowbTJLM1MCBPAJgEPqHNgXPOc-EHturKRaGJYKy3KdWFYwLVJm2RO0Wze1fYawsw6mBOsK6GWepkKDNUiFA1BaJmkhzAgdrbpUmSEouefGmCkwTrwQVBCC8kJQQQgj9Gb9xXUMyPGPvMdeSut8PpR2eNAsLtUwMpVziYPmlGMDtZNWF6IEjAe4p8wCgh6hlysZKxh6_jxF17bpW0X9ZAaToMhG6GmU-boo5iPrcw5VSDe0YaMum2_q6iqE95YMIINI9_6j3H10F1qbhy0h_hztdovevgCQ1BUHYXMB0s_T5CAo_W-ciRJI |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Changes+in+Mycobacterium+tuberculosis-Specific+Immunity+With+Influenza+co-infection+at+Time+of+TB+Diagnosis&rft.jtitle=Frontiers+in+immunology&rft.au=Mendy%2C+Joseph&rft.au=Jarju%2C+Sheikh&rft.au=Heslop%2C+Rhiannon&rft.au=Bojang%2C+Adama+L&rft.date=2019-01-04&rft.issn=1664-3224&rft.eissn=1664-3224&rft.volume=9&rft.spage=3093&rft_id=info:doi/10.3389%2Ffimmu.2018.03093&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1664-3224&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1664-3224&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1664-3224&client=summon |